Intertrigo
ICD-10 L30.4 · ICD-11 EK02.20, 1F23.12

Treatment of Intertrigo Complicated by Cutaneous Erythrasma (Corynebacterium minutissimum)

When intertrigo in the skin folds is complicated by Corynebacterium minutissimum superinfection, it requires targeted antibiotic management beyond standard skin-fold care. Wood lamp examination is key to confirming the diagnosis before selecting a treatment approach.

Clinical Scenario

Intertrigo complicated by cutaneous erythrasma — a bacterial superinfection caused by Corynebacterium minutissimum. Skin lesions fluoresce coral-red on Wood lamp examination, distinguishing this from uncomplicated intertrigo and directing antibiotic therapy.

Treatment Approach

Erythromycin — available in both topical and oral formulations — is the primary treatment for cutaneous erythrasma complicating intertrigo. Oral therapy is generally considered more effective than topical application alone.

Additional antibiotic agents may also have a role. The complete regimen — including formulation selection, sequencing, and all evidence-based alternatives — is available in the full protocol.

Treatment goal: Resolution of the rash in the affected skin folds.

Instant Access to Structured Evidence-Based Regimens

References

View source ↗